Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-05

Clinical Trial Update: CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on CyberKnife radiosurgical treatment for inoperable early-stage non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CyberKnife radiosurgical treatment

Snippet

Sponsor: Accuray Incorporated | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN